SLigezka, A. N., Radenkovic, S., Saraswat, M., Garapati, K., Ranatunga, W., Krzysciak, W., Yanaihara, H., Preston, G., Brucker, W., McGovern, R. M., Reid, J. M., Cassiman, D., Muthusamy, K., Johnsen, C., Mercimek-Andrews, S., Larson, A., Lam, C., Edmondson, A. C., Ghesquière, B., Witters, P., … Morava, E. (2021). Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications. Annals of neurology. 90, 887–900. [PubMed]